Most men do not notice male pattern hair loss in the mirror. They notice it in a photograph — a group shot taken from slightly above, in flat overhead light, where the corners of the hairline have quietly moved back and the brow looks taller than it did three years ago.
That corner recession is not a cosmetic footnote. It is usually the opening move. According to MedlinePlus Genetics, in men with androgenetic alopecia “hair is lost in a well-defined pattern, beginning above both temples,” and over time the hairline “recedes to form a characteristic ‘M’ shape,” with thinning at the top of the head following. The same resource notes that more than half of men over the age of 50 have some degree of hair loss.
What makes the temples awkward is not that they are hard to see. It is that the two best-evidenced drug treatments for male pattern hair loss were not really studied there, and their own regulatory labelling says so. That gap is worth understanding properly, because it shapes every decision a man makes afterwards, including the decision to do nothing.
What is actually happening above the temples
Androgenetic alopecia is not so much hair falling out as hair getting smaller. MedlinePlus describes the mechanism as excessive stimulation of hair follicles by androgens leading to “a shorter growth period, resulting in shorter and thinner strands of hair.” Repeated over years, a thick terminal hair becomes a fine, short, barely pigmented one, and eventually the follicle stops producing a visible hair at all. Clinicians call this miniaturisation.
The practical consequence is a window. Early on, the follicle is still alive and shrinking, and a treatment that reduces the hormonal signal or stimulates growth has something to work with. Later, when the follicle is dormant, there is much less left to stimulate. This is why the American Academy of Dermatology observes that “the men who tend to see the best results start treatment soon after noticing hair loss.”
The temples are difficult precisely because they are early and advanced at the same time: early in the overall course of a man’s hair loss, but often already well down the miniaturisation path in that specific zone. The staging systems in routine clinical use — the Norwood–Hamilton classification is the common one — place bitemporal recession among the first recognised stages.
The evidence gap at the hairline, in the manufacturers’ own words
This is the part a reader can verify in an afternoon.
Topical minoxidil. The over-the-counter Drug Facts labelling for 5% minoxidil topical solution gives the use as “to regrow hair on the top of the scalp (vertex only)” and then says plainly: “5% minoxidil topical solution is not intended for frontal baldness or receding hairline.” The same label notes that “continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again.”
Oral finasteride. The FDA-approved labelling for finasteride 1 mg carries the line “Efficacy in bitemporal recession has not been established.” The pivotal hair-count data were gathered in the vertex and anterior mid-scalp, not at the temporal corners.
Neither statement means these drugs are useless to a man with receding temples. Both act on the underlying process across the scalp, and slowing the progression that is coming for the mid-scalp is a legitimate goal in its own right. But “we have not demonstrated an effect here” is a materially different proposition from “this will restore your hairline,” and men deserve to be told which one they are buying.
The British Association of Dermatologists notes that finasteride reduces dihydrotestosterone levels and that “decreased libido and erectile problems are recognised side-effects in approximately 2% of patients.” The AAD’s patient guidance additionally lists breast tenderness and depression among possible effects, and notes that some can persist after stopping. Finasteride is prescription-only in most markets and not a drug to begin without a clinical conversation. In the UK neither drug is available on NHS prescription, and the NHS notes that these treatments “only work for as long as they’re used.”
Surgery is the only option that moves real follicles
Hair transplantation relocates follicles from the permanent donor zone at the back and sides of the scalp into the thinning area. The BAD describes the procedure in those terms and notes that in the UK it is not offered on the NHS and must be sought privately. The AAD’s position is that a modern transplant “can give you permanent, natural-looking results,” a change it attributes to surgeons now moving healthy hairs a few at a time rather than in the large plugs used in the 1970s and 80s.
Two caveats belong in any honest account. The first is timing: transplanted hair is permanent, but the untransplanted hair around it is not, so a hairline rebuilt while loss is still progressing can end up stranded ahead of a receding field. This is why surgeons frequently want a patient stabilised on medical treatment first. The second is that a transplant is surgery, with a recovery period, a real cost, and results measured in months rather than weeks.
The options side by side
| Option | Time to visible difference | Reversible | Cost pattern | Effect on the underlying loss |
| Topical 5% minoxidil | Months; the label cites 2 to 4 months of twice-daily use | Yes — gains are lost on stopping | Low, recurring, indefinite | Acts on the process; labelled for the vertex, not the hairline |
| Oral finasteride (prescription) | Months; the AAD cites around 6 | Yes — effect ends on stopping | Low to moderate, recurring, indefinite | Acts on the process; efficacy at bitemporal recession not established |
| Hair transplant surgery | Months, after a recovery period | No — surgical and permanent | Substantial one-off, private in most markets | Relocates living follicles; does not stop loss elsewhere |
| Fibres, sprays and concealers | Immediate | Yes — washes out | Low, recurring | None; camouflage only, and the BAD notes these can wash away if the hair gets wet |
| Partial hair system or hair patch | Immediate | Yes — removable | Moderate, recurring as units are replaced | None; physical coverage only |
The bottom two rows are not treatments. Including them alongside the top three is only defensible if that distinction is stated out loud.
What a partial patch actually is, and what it is not
A partial hair system is a small piece of human or synthetic hair on a thin base, adhered to the scalp over a specific bald or thinning area. Unlike a wig, it covers a zone rather than the whole head. A temple patch is the smallest version of the idea: two small pieces addressing the recessed corners only, leaving the rest of the hairline alone.
It does nothing to androgenetic alopecia. It does not regrow hair, halt miniaturisation, or alter dihydrotestosterone. It covers. What it offers instead is the two things the medical options cannot: the result is visible the day it is applied, and it is entirely reversible — the unit comes off and the scalp underneath is unchanged.
What to look for if you are assessing one
Three specifications do most of the work, and all three are checkable before purchase.
Base thickness at the front edge. This is what determines whether the hairline reads as a hairline or as an edge. Thin transparent polyurethane — “skin” — bases are measured in fractions of a millimetre, and the figure at the leading edge matters more than the average. As a concrete example, one temple-specific hair patch for men publishes a thinnest point of 0.06 mm on a transparent skin base with V-looped hair throughout, a 3″ x 2.5″ base and an expected working life of two to three months — the kind of figures that let a buyer judge a product before committing to it rather than after.
The hair itself. For a patch sitting at the front of the head in daylight, human hair, a density matched to the surrounding scalp rather than the densest available, and a freestyle or undirected parting will look more plausible than a dense, pre-parted unit. Over-density at the hairline is the single most common giveaway.
Attachment and removal. Adhesive systems use tape or liquid glue, and removal generally requires a citrus-oil or alcohol-based solvent. Anyone with sensitive skin, eczema, seborrhoeic dermatitis or a known adhesive allergy should patch-test and raise it with a clinician first, because the adhesive sits directly on skin that is already exposed.
The decision
Anyone noticing recession at the temples should get a proper assessment from a dermatologist or a qualified trichologist before committing to anything. Not all hair loss is androgenetic, some causes are treatable, and the NHS specifically advises seeing a doctor about hair loss before approaching a commercial hair clinic.
After that, the choice is genuinely a choice, not one between a good option and a bad one. It is between acting on the biology, and accepting that the visible result is slow, partial and conditional on continuing; having surgery, and accepting cost, recovery and the need to plan around future loss; covering it, and accepting that nothing underneath has changed; or doing nothing, which remains a legitimate answer and one the AAD is careful to leave open.
A partial patch is at least honest about what it is. It buys appearance, immediately and reversibly, and it buys nothing else. For a man who wants his photographs to stop bothering him while he decides what to do about the underlying condition — or who has decided not to do anything about it — that is a coherent position, provided nobody pretends it is medicine.
